Medulloblastoma/primitive neuroectodermal tumour studied as a Matrigel enhanced subcutaneous xenograft model

Journal of Clinical Neuroscience

Volumn 8, Issue 2, 2001, Pages 151-156

  White, Les ^a   Sterling Levis, Katy ^a   Kees, Ursula R ^b   Tobias, Vivienne ^a  

^a SYDNEY CHILDREN'S HOSPITAL   (Australia)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

Brain tumour; Chemotherapy; Child; Matrigel; Nude mouse; Xenograft

Indexed keywords

CARBOPLATIN; CISPLATIN; CYCLOPHOSPHAMIDE; DIAZIQUONE; MATRIGEL; SODIUM CHLORIDE; VINCRISTINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN TUMOR; CELL SUSPENSION; COHORT ANALYSIS; CONTROLLED STUDY; MEDULLOBLASTOMA; MOUSE; NEUROECTODERM TUMOR; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; STATISTICAL ANALYSIS; XENOGRAFT;

EID: 0035088403     PISSN: 09675868     EISSN: None     Source Type: Journal    
DOI: 10.1054/jocn.2000.0734     Document Type: Article

References (55)

1. Heterogeneous response to chemotherapy of human gliomas grown in nude mice and as clones in vitro
2. Treatment of human glioma and medulloblastoma tumor lines in athymic mice with diaziquone and diaziquone-based drug combinations
3. Development and characterization of human ependymoma xenograft HxBr5
4. 6benzylguanine and 1,3-bis(2-chloroethyl)-nitrosourea
5. Characterization of five new cell lines derived from human primitive neuroectodermal tumors of the central nervous system
6. Establishment and characterization of the human medulloblastoma cell line and transplantable xenograft D283 Med
7. A xenograft model for the study of brain tumours
8. Response of brain tumors to chemotherapy, evaluated in a clinically relevant xenograft model
9. Enhanced tumor growth of both primary and established human and murine tumor cells in athymic mice after coinjection with Matrigel
10. Transplantation of human prostatic carcinoma into nude mice in Matrigel
11. Role of basement membrane and laminin in metastases and tumor growth
12. Basement membrane components (Matrigel) promote the tumorigenicity of human breast adenocarcinoma MCF7 cells and provide an in vivo model to assess the responsiveness of cells to estrogen
13. Effect of Matrigel on the tumorigenicity of human breast and ovarian carcinoma cell lines
14. The effect of Matrigel on the growth of glioma cells in vitro and in vivo
15. Effects of Matrigel on the SF-767 malignant glioma athymic mouse tumor model
16. Reconstituted basement membrane (Matrigel) enhances the growth of human glioma cell lines in nude mice
17. Heterotransplantation of early B-lineage acute lymphoblastic leukemia using a solubilized attachment matrix (Matrigel)
18. PER 117: A new human ALL cell line with an immature thymic phenotype
19. A new pineoblastoma cell line, PER-480, with der(10)t(10;17), der(16)t(1;16), and enhanced expression of the MYC gene
20. Comparison of cyclophosphamide and diaziquone in a retinoblastoma xenograft model
21. Evaluation of response to chemotherapy in retinoblastoma heterotransplanted to the eyes of nude mice
22. Responsiveness of retinoblastoma to local diaziquone. Studies in a xenograft model
23. Determination of subcutaneous tumour size in athymic (nude) mice
24. Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment
25. Non-barometic estimation from incomplete observations
26. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examples
27. Amplification of the c-myc gene in human medulloblastoma cell lines and xenografts
28. Expression of major histocompatibility complex on human medulloblastoma cells with neuronal differentiation
29. Differentiation characteristics of newly established medulloblastoma cell lines (D384 Med, D425 Med, and D458 Med) and their transplantable xenografts
30. Immunophenotype profile of childhood medulloblastomas and supratentorial primitive neuroectodermal tumors using 16 monoclonal antibodies
31. Differentiation in the medulloblastoma. A histological and immunohistochemical study
32. Human brain tumour xenografts in nude mice as a chemotherapy model
33. Intracerebral growth of human glioma tumor line in athymic mice and treatment with procarbazine, 1,3 bis(2chloroethyl)-1-itrosourea, aziridinylbenzoquinone, and cis-platinum
34. Experimental chemotherapy of human medulloblastoma cell lines and transplantable xenografts with bifunctional alkylating agents
35. Increased melphalan activity in intracranial human medulloblastoma and glioma xenografts following buthionine sufoxamine-mediated glutathione depletion
36. Development of a xenograft glioma model in mouse brain
37. A rapid screening method for testing chemotherapeutic agents against human tumour xenografts
38. Chemotherapy responsiveness of brain tumors in subrenal capsule assay
39. Brain tumor growth and response to chemotherapy in the subrenal capsule assay
40. Phenotypic and genotypic analysis of a human medulloblastoma cell line and transplantable xenograft (D341 Med) demonstrating amplification of c-myc
41. Establishment of a human medulloblastoma cell line and its heterotransplantation into nude mice
42. Establishment and biological characterization of human medulloblastoma cell lines
43. Basement membrane complexes with biological activity
44. Dose-intensive cyclophosphamide with etoposide and vincristine for paediatric solid tumors: A phase I/II pilot study by the Australia and New Zealand Childhood Cancer Study Group
45. A dose intensive, cyclophosphamide-based regimen (VETOPEC) for relapsed progressive or advanced solid tumors of childhood: A report from the Australian and New Zealand Children's Cancer Study Group
46. Postoperative chemotherapy and delayed radiation in children less than three years of age with malignant brain tumors
47. Cyclophosphamide therapy of medulloblastoma: From the laboratory to the clinic and back again (and again and again)
48. The clinical pharmacology of antineoplastic agents (first of two parts)
49. Reversible osmotic blood brain barrier disruption?
50. Reversible osmotic blood-brain barrier disruption in humans: Implications for the chemotherapy of malignant brain tumors
51. Affinity of antineoplastic amino acid drugs for the large neutral amino acid transporter of the blood-brain barrier
52. Do anticancer agents reach the tumor target in the human brain?
53. Establishment and characterization of a human T-cell leukemia line (LALW-2) in nude mice
54. Heterotransplantation of human lymphoid neoplasms using a nude mouse intraocular xenograft model